207 related articles for article (PubMed ID: 38474244)
1. Study on the Mechanism of the Adrenaline-Evoked Procoagulant Response in Human Platelets.
Gołaszewska A; Misztal T; Kazberuk A; Rusak T
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474244
[TBL] [Abstract][Full Text] [Related]
2. Sodium-Calcium Exchanger Reverse Mode Sustains Dichotomous Ion Fluxes Required for Procoagulant COAT Platelet Formation.
Aliotta A; Bertaggia Calderara D; Zermatten MG; Alberio L
Thromb Haemost; 2021 Mar; 121(3):309-321. PubMed ID: 33099282
[TBL] [Abstract][Full Text] [Related]
3. Conventional protein kinase C isoforms differentially regulate ADP- and thrombin-evoked Ca²⁺ signalling in human platelets.
Lever RA; Hussain A; Sun BB; Sage SO; Harper AG
Cell Calcium; 2015 Dec; 58(6):577-88. PubMed ID: 26434503
[TBL] [Abstract][Full Text] [Related]
4. Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.
Lages B; Weiss HJ
Br J Haematol; 2001 Apr; 113(1):65-71. PubMed ID: 11328283
[TBL] [Abstract][Full Text] [Related]
5. P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.
Berny-Lang MA; Jakubowski JA; Sugidachi A; Barnard MR; Michelson AD; Frelinger AL
J Am Heart Assoc; 2013 May; 2(3):e000026. PubMed ID: 23676293
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein IIb/IIIa receptor antagonists inhibit the development of platelet procoagulant activity.
Pedicord DL; Thomas BE; Mousa SA; Dicker IB
Thromb Res; 1998 Jun; 90(6):247-58. PubMed ID: 9700855
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein IIb/IIIa blockade inhibits platelet aminophospholipid exposure by potentiating translocase and attenuating scramblase activity.
Razmara M; Hu H; Masquelier M; Li N
Cell Mol Life Sci; 2007 Apr; 64(7-8):999-1008. PubMed ID: 17372676
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
Matsumoto Y; Marukawa K; Okumura H; Adachi T; Tani T; Kimura Y
Thromb Res; 1999 Jul; 95(1):19-29. PubMed ID: 10403683
[TBL] [Abstract][Full Text] [Related]
9. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
10. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
11. The involvement of Na+/K(+)-ATPase in the development of platelet procoagulant response.
Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
Acta Biochim Pol; 2007; 54(3):625-39. PubMed ID: 17653302
[TBL] [Abstract][Full Text] [Related]
12. alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels.
Keularts IM; van Gorp RM; Feijge MA; Vuist WM; Heemskerk JW
J Biol Chem; 2000 Jan; 275(3):1763-72. PubMed ID: 10636873
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia.
Aliotta A; Krüsi M; Bertaggia Calderara D; Zermatten MG; Gomez FJ; Batista Mesquita Sauvage AP; Alberio L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327658
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase.
Kang WS; Chung KH; Chung JH; Lee JY; Park JB; Zhang YH; Yoo HS; Yun YP
J Cardiovasc Pharmacol; 2001 Dec; 38(6):875-84. PubMed ID: 11707691
[TBL] [Abstract][Full Text] [Related]
15. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
16. Adrenaline May Contribute to Prothrombotic Condition via Augmentation of Platelet Procoagulant Response, Enhancement of Fibrin Formation, and Attenuation of Fibrinolysis.
Golaszewska A; Misztal T; Marcinczyk N; Chabielska E; Rusak T
Front Physiol; 2021; 12():657881. PubMed ID: 34025450
[No Abstract] [Full Text] [Related]
17. Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists.
Dickfeld T; Ruf A; Pogatsa-Murray G; Müller I; Engelmann B; Taubitz W; Fischer J; Meier O; Gawaz M
Thromb Res; 2001 Jan; 101(2):53-64. PubMed ID: 11342206
[TBL] [Abstract][Full Text] [Related]
18. Platelet hyperprocoagulant activity in Type 2 diabetes mellitus: attenuation by glycoprotein IIb/IIIa inhibition.
Razmara M; Hjemdahl P; Ostenson CG; Li N
J Thromb Haemost; 2008 Dec; 6(12):2186-92. PubMed ID: 18983513
[TBL] [Abstract][Full Text] [Related]
19. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation.
Alberio L; Ravanat C; Hechler B; Mangin PH; Lanza F; Gachet C
Thromb Haemost; 2017 Jun; 117(6):1101-1114. PubMed ID: 28382366
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the Na+/H+ exchanger in membrane phosphatidylserine exposure during human platelet activation.
Bucki R; Pastore JJ; Giraud F; Janmey PA; Sulpice JC
Biochim Biophys Acta; 2006 Feb; 1761(2):195-204. PubMed ID: 16459134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
